Menu

Sign in

Sign in

Contact us

Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

Eavesdropping on the pH levels inside the brain

Eavesdropping on the pH levels inside the brain

Researchers at Tohoku University have developed the first all-in-one miniature pH probe for real-time investigations of intrinsic extracellular pH dynamics in the deep brain structures.

U.S. FDA puts early-stage trial of Altimmune's COVID-19 vaccine on hold

U.S. FDA puts early-stage trial of Altimmune's COVID-19 vaccine on hold

(Reuters) - Altimmune Inc said on Wednesday the U.

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19 Save

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19 Save

China's Covid-19 vaccine over 50% effective, but Sinovac withholds data

China's Covid-19 vaccine over 50% effective, but Sinovac withholds data

A Covid-19 vaccine developed by Chinese pharmaceutical firm Sinovac Biotech Ltd.

Research team reports new class of antibiotics active against a wide range of bacteria

Research team reports new class of antibiotics active against a wide range of bacteria

Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response...

Brazil institute says CoronaVac efficacy above 50%, but delays full results

Brazil institute says CoronaVac efficacy above 50%, but delays full results

RIO DE JANEIRO (Reuters) - Brazilian researchers said on Wednesday the COVID-19 vaccine developed by China’s Sinovac Biotech is more than 50% effective based on trial data, but again wit...

Takeda offloads heart and metabolism drugs to 3-month-old Chinese firm for $322M

Takeda offloads heart and metabolism drugs to 3-month-old Chinese firm for $322M

Takeda has already exceeded the product sell-off goal it set alongside its Shire merger, but the Japanese pharma shows no sign of slowing down.

Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal

Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal

BASEL, Switzerland and CAMBRIDGE, Mass.

U.S. Government Secures 100 Million More Pfizer-BioNTech COVID-19 Vaccine Doses

U.S. Government Secures 100 Million More Pfizer-BioNTech COVID-19 Vaccine Doses

Pfizer and BioNTech have reached an agreement with the Trump administration on supplying more of their COVID-19 vaccine.

How our brains help us find misplaced objects

How our brains help us find misplaced objects

Have you ever wondered how we remember the last place we saw our car keys or other objects like mobile phones and glasses?This new research shows we have a type of brain cell that’s sensitive to the...

Supernus drug meets main goal of study in adults with ADHD

Supernus drug meets main goal of study in adults with ADHD

(Reuters) - Supernus Pharmaceuticals Inc said on Tuesday its experimental drug for attention deficit hyperactivity disorder (ADHD) met the main goal of a late-stage study in adults.

Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth

Nephron Announces FDA Approval of Ketorolac, Signaling New Phase of Growth

WEST COLUMBIA, S.

123 4 5 6

0 items in Cart

Cart Subtotal:

You will be able to Pay Online or Request a Quote